best glp-1 agonist companies Research shows drugs are effective but complex GLP-1 Medications for Weight Loss:

Lin, W.-Y

The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with chronic kidney disease and type 2 diabetes

Tirzepatide: Does Your Drug Choice Affect Muscle Outcomes

Cohen JD, Brinton EA, Ito MK, Jacobson TA

This pathway also supports cell survival and proliferation, helping maintain sufficient cell mass to sustain normal insulin output

Available from: Liao C, Liang X, Zhang X, Li Y (2023) The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population with or without diabetes and nonalcoholic fatty liver disease: a systematic review and meta-analysis